Randomized Trial to Prevent Postpartum Smoking Relapse by Promoting Breastfeeding and Supporting Maternal and Infant Health

What this Trial Is About

This trial studies pregnant women who quit smoking during pregnancy to evaluate if promoting breastfeeding can prevent postpartum smoking relapse and improve health for both mother and child. The research aims to understand the effects of breastfeeding promotion on smoking relapse, breastfeeding habits, and the health of mothers and infants. It also investigates how stress, mother-infant bonding, and maternal weight changes might influence these outcomes. Participants will be randomly assigned to either a breastfeeding promotion group or an attention control group. The breastfeeding intervention includes education, lactation counseling, social support, financial incentives linked to breastfeeding, and optional early limited formula feeding for at-risk infants. The control group receives general infant care counseling and support. Both groups continue to receive usual care for postpartum smoking relapse including information and Quitline support. This study follows participants from late pregnancy through 12 months postpartum. During the study, participants will be monitored for smoking relapse and breastfeeding practices up to one year after birth. Maternal and infant health measurements such as blood pressure and infant growth metrics will also be collected. Researchers will evaluate outcomes including the number of mothers who resume smoking and those who breastfeed at 12 months postpartum. This comprehensive approach aims to track health effects and support lasting smoking abstinence.

Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion